Ocera Therapeutics, Inc. (NASDAQ: OCRX) is a clinical stage biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease. The company’s leading product candidate, OCR-002, is currently being studied in phase IIb clinical trials for the treatment of hyperammonemia and resultant hepatic encephalopathy in patients with […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.